In this June 9th, 2017 congressional briefing, Beau Kilmer, codirector of the RAND Drug Policy Research Center, provides an overview of recent changes in marijuana policies as well as options for the federal government.
The report sets out the findings of an evaluation that assesses the degree of implementation of the EU Drugs Strategy 2013-2020 and the Action Plan 2013-2016 in all 28 EU Member States in terms of outputs and, where possible, impacts.
Data lags and the elimination of the ADAM program complicate estimates of U.S. cocaine consumption. New users who haven't yet developed cocaine dependence are also a factor. It may be prudent to start planning for an increase in heavy use even before all of the evidence is in.
The new administration has at least six options for addressing marijuana. These are not mutually exclusive, and each comes with tradeoffs. All six are compatible with a federal approach that encourages discussions about prohibition and its alternatives.
There are many ways to legalize marijuana supply besides the for-profit approach. But to learn what effects various models have, the federal government will have to make it easier for states to implement some middle-ground options.
A mandatory public consultation was conducted to inform the Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and the final evaluation of the EU Action Plan on Drugs 2013-2016. This document reports on the consultation's results.
Harmonizing measurement of drug policy indicators, such as prevalence of use, problematic use, and drug enforcement, would help improve cross-national comparisons of how nations deal with illicit drugs.
Respondent-driven sampling -- a peer-driven method of recruiting hidden populations -- can be used to create a representative sample of a drug market's users; the sample can then be surveyed to discern the effects of a Drug Market Intervention.
Setting the cannabis tax should not be considered a one-time event. Smart jurisdictions will revise their decisions over time to incorporate new data about taxes, testing, and the cannabis plant itself — without being influenced by those seeking to maximize profits.
This study of cocaine and heroin distribution networks in Italy and Slovenia explores a new approach to modeling such networks and identifying different market levels, defined by the quantity and frequency of sales and ranging from international brokers to wholesale distributors to retail dealers.
Beau Kilmer, co-director of the RAND Drug Policy Research Center and a co-author of the nonpartisan primer Marijuana Legalization: What Everyone Needs to Know addresses developments in marijuana policy and why reasonable people can disagree about legalization.
Vermonters spend between $125 and $225 million on marijuana each year. There are many factors to consider when projecting the budgetary effects legalization might have, but policy changes do not need to be permanent. Starting with incremental change and/or incorporating a sunset provision might make more sense.